World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of …
These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in …
Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in …
The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review
J Peuskens, L Pani, J Detraux, M De Hert - CNS drugs, 2014 - Springer
Since the 1970s, clinicians have increasingly become more familiar with hyperprolactinemia
(HPRL) as a common adverse effect of antipsychotic medication, which remains the …
(HPRL) as a common adverse effect of antipsychotic medication, which remains the …
Almost all antipsychotics result in weight gain: a meta-analysis
M Bak, A Fransen, J Janssen, J van Os, M Drukker - PloS one, 2014 - journals.plos.org
Introduction Antipsychotics (AP) induce weight gain. However, reviews and meta-analyses
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …
generally are restricted to second generation antipsychotics (SGA) and do not stratify for …
Non‐adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
JM Kane, T Kishimoto, CU Correll - World psychiatry, 2013 - Wiley Online Library
Although non‐adherence is common across all branches of medicine, psychotic disorders
pose additional challenges that increase its risk. Despite the importance of non‐adherence …
pose additional challenges that increase its risk. Despite the importance of non‐adherence …
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of …
These updated guidelines are based on a first edition of the World Federation of Societies of
Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …
Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia …
A response to reimportation
M Newcomer - Structure, 2005 - cell.com
In this issue of Structure, Holmes et al.(2005) describe elements of an innate defense
mechanism that provides mammals a means to restrict bacterial growth. The host protein …
mechanism that provides mammals a means to restrict bacterial growth. The host protein …
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto, GE Duncan, CE Marx… - Molecular psychiatry, 2005 - nature.com
The treatment of schizophrenia has evolved over the past half century primarily in the
context of antipsychotic drug development. Although there has been significant progress …
context of antipsychotic drug development. Although there has been significant progress …
Obesity among those with mental disorders: a National Institute of Mental Health meeting report
DB Allison, JW Newcomer, AL Dunn… - American journal of …, 2009 - Elsevier
The National Institute of Mental Health convened a meeting in October 2005 to review the
literature on obesity, nutrition, and physical activity among those with mental disorders. The …
literature on obesity, nutrition, and physical activity among those with mental disorders. The …
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.
RM Berman, RN Marcus, R Swanink… - Journal of Clinical …, 2007 - psychiatrist.com
Objective: To assess the efficacy and safety of aripiprazole versus placebo as adjunctive
treatment to standard antidepressant therapy (ADT) in patients with major depressive …
treatment to standard antidepressant therapy (ADT) in patients with major depressive …
Dopamine partial agonists: a new class of antipsychotic
JA Lieberman - CNS drugs, 2004 - Springer
This review examines the development of dopamine partial agonists as a new class of
antipsychotic agents. Partial agonists have a lower intrinsic activity at receptors than full …
antipsychotic agents. Partial agonists have a lower intrinsic activity at receptors than full …